Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: GlaxoSmithKline Research & Development Ltd
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
A 12-week study to test lung function in people with COPD
The primary objective of the study is to evaluate the contribution on lung function (as measured by trough FEV1) of FF 100 mcg to FF/VI 100/25mcg QD by the comparison of the latter with VI 25mcg QD (e...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
An Open Label Continuation Study of the Oral AKT Inhibitor GSK2110183 in Subjects with Solid Tumors and Hematologic Malignancies
The primary objective of the study is to provide treatment with afuresertib for subjects who have previously participated in an afuresertib study sponsored by GSK or another research organization work...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
Effect of Otelixizumab in New-Onset Type 1 Diabetes Mellitus (NOT1DM)
To assess the effect of a single course of otelixizumab treatment on the acute and long term safety and tolerability of otelixizumab in NOT1DM patients.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
Albiglutide versus Placebo in New-Onset Type 1 Diabetes Mellitus
• Determine the effect of albiglutide therapy versus placebo on endogenous insulin secretion over 52 weeks when added to standard of care in subjects with new onset type 1 diabetes mellitus (NOT1DM)
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
A randomised, double-blind, placebo-controlled, Bayesian adaptive dose finding study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat intravenous infusions GSK315234A in patients with active rheumatoid arthritis (RA)
To assess: 1) safety and tolerability of GSK315234A after single and repeat i.v. infusions in subjects with active RA on background of methotrexate (MTX). 2) effect of GSK315234A on disease activity ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
A safety study for subjects with severe asthma who participated in MEA115575 or MEA115588
To describe the safety profile of mepolizumab in subjects receiving long-term treatment
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
A 28-Day, Polysomnographic and Subjective Assessment of Vestipitant (15mg/day) for the Treatment of Primary Insomnia in Adult Outpatients
• To compare the efficacy of oral vestipitant (15mg/day) with placebo after 4 weeks of nightly treatment in adult outpatients diagnosed with primary insomnia, as determined objectively by polysomnogra...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
A randomized, parallel group study to evaluate the effect of Umeclidinium (UMEC) added to Inhaled corticosteroid/ long-acting beta-agonist combination therapy in subjects with Chronic Obstructive Pulmonary Disease COPD
The primary objective is to evaluate the efficacy and safety of the addition of UMEC 62.5mcg once-daily to ICS/LABA therapy, compared with placebo once-daily plus ICS/LABA therapy over 12 weeks in sub...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
Clincial Study of Fluticasone Propionate/ Salmeerol and Fluticasone Propionate in the treatment of Asthma patients
The primary objective of this study was to demonstrate that FSC DISKUS 250/50 BID is superior to FP DISKUS 250 BID at increasing pulmonary function as measured by forced expiratory volume in one secon...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
GlaxoSmithKline Research & Development Ltd
Update Il y a 5 ans
Study to evaluate the effectiveness of fluticasone furoate/vilanterol delivered once daily via a Novel Dry Powder Inhaler (NDPI) compared with existing COPD maintenance therapy alone in subjects with Chronic Obstructive Pulmonary Disease
The objective of the study is to compare the effectiveness and safety of fluticasone furoate (FF)/vilanterol (VI) Inhalation Powder 100mcg/25mcg with other maintenance therapy over twelve months in a ...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
2
3
4
5
6
7
8
9
10
11
Next